Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and highly prevalent ...

Collaboration Revenue: There was $2.3 million of collaboration revenue for the year ended December 31, 2024, as compared to no collaboration revenue for the year ended December 31, 2023. The increase ...

Synthetic biology specialist GRO Biosciences started exploring strategic alternatives about six months after raising a series ...

Peptides designed by artificial intelligence restrict both drug-resistant bacteria and rapidly evolving viruses.

As part of an interview series Matt Hyde, Director of Recruit121 and FinTech Awards Wales, talks to a whole host of ...

Biopharma companies require optimal clone yields to ensure maximum concentration and effectiveness of these therapeutic ...

The ISC class 12 Biology exam is one of the most important exams for students aiming to excel in science. Understanding the ...

Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on ...

Trimtech Therapeutics has closed a seed funding round of $31m (£25m) to advance its pipeline of the central nervous system (CNS)-penetrant therapeutics that are based on Trimtacs, the ...

Our results point to two interesting findings — 1) using only codon frequency as the feature representation results in a modest boost in performance over RSCU (p = 0.024, Wilcoxon rank test) in ...

Scientists dive into the genomes of whales, elephants, and other animal giants looking for new weapons in the fight against ...

The authors' demonstration that impaired olfactory perception reduces caterpillar performance and increases susceptibility to parasitism is solid. These findings highlight the ecological significance ...